Medical Device | May 11, 2026
Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
